Log | Progress In Mind

Log Type	Authored on	Log Message	Log Node	Authored by
Newsletter clicked	Tue, 11/08/2022 - 13:18	Clicked https://za.progress.im/en/content/are-antipsychotics-needed-long-term-treatment-schizophrenia		Анонимен
Newsletter clicked	Tue, 11/08/2022 - 13:18	Clicked https://za.progress.im/en/event/covid-19-south-africa		Анонимен
Newsletter clicked	Tue, 11/08/2022 - 13:18	Clicked https://za.progress.im/en/content/expert-view-page-0		Анонимен
Newsletter clicked	Tue, 11/08/2022 - 13:18	Clicked https://za.progress.im/en/content/new-earn-cpd-points-online-now		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Анонимен
Newsletter sent	Tue, 11/08/2022 - 13:18	Newsletter Test sent to:sly@lundbeck.com		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Анонимен
OWA Status	Wed, 10/12/2022 - 13:23	Updating trust level from 1 to 2		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Анонимен
User created	Wed, 10/12/2022 - 13:23	User created		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Dra. Deborah Dunsire (CEO Lundbeck) envia mensagem aos profissionais saúde durante a crise do COVID-19	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Анонимен

Log Type	Authored on	Log Message	Log Node	Authored by
Newsletter clicked	Tue, 11/08/2022 - 13:18	Clicked https://za.progress.im/en/content/are-antipsychotics-needed-long-term-treatment-schizophrenia		Анонимен
Newsletter clicked	Tue, 11/08/2022 - 13:18	Clicked https://za.progress.im/en/event/covid-19-south-africa		Анонимен
Newsletter clicked	Tue, 11/08/2022 - 13:18	Clicked https://za.progress.im/en/content/expert-view-page-0		Анонимен
Newsletter clicked	Tue, 11/08/2022 - 13:18	Clicked https://za.progress.im/en/content/new-earn-cpd-points-online-now		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Анонимен
Newsletter sent	Tue, 11/08/2022 - 13:18	Newsletter Test sent to:sly@lundbeck.com		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Анонимен
OWA Status	Wed, 10/12/2022 - 13:23	Updating trust level from 1 to 2		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Анонимен
User created	Wed, 10/12/2022 - 13:23	User created		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Dra. Deborah Dunsire (CEO Lundbeck) envia mensagem aos profissionais saúde durante a crise do COVID-19	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Анонимен

Patrocinado por

Progress in Mind Brazil

INSCRIÇÃO NEWSLETTER